Back
INmune Bio Vs. Monopar Therapeutics Industry Stock Comparison
Sell
25
INMB
INmune Bio
Last Price:
$7.25
Seasonality Move:
24.71%
Sell
17
MNPR
Monopar Therapeutics
Last Price:
$29.48
Seasonality Move:
-9.44%
Sell
25
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
-
The current INmune Bio [INMB] share price is $7.27. The Score for INMB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $30.00. The Score for MNPR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $7.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INMB is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
INMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 43.21 | Sell |
Chaikin Money Flow: | -214435 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.56 - 8.34) | Sell |
Bollinger Bands (100): | (5.11 - 8.57) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 41.89 | Sell |
Chaikin Money Flow: | -19867 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.35 - 39.15) | Sell |
Bollinger Bands (100): | (21.11 - 40.13) | Sell |
INMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.65 | Sell |
20-day SMA: | 7.94 | Sell |
50-day SMA: | 8.41 | Sell |
200-day SMA: | 6.82 | Buy |
8-day EMA: | 7.71 | Sell |
20-day EMA: | 7.9 | Sell |
50-day EMA: | 7.8 | Sell |
200-day EMA: | 7.42 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.6 | Sell |
20-day SMA: | 35.41 | Sell |
50-day SMA: | 38.47 | Sell |
200-day SMA: | 17.81 | Buy |
8-day EMA: | 35.31 | Sell |
20-day EMA: | 36.03 | Sell |
50-day EMA: | 35.03 | Sell |
200-day EMA: | 22.36 | Buy |
INmune Bio Earnings Growth & INMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.16 per share, an increase this year of $0.44 per share, and an increase next year of $0.09 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
INmune Bio Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |